Recent patterns of bladder cancer incidence and mortality: a global overview

WCRJ 2020; 7 : e1464
DOI: 10.32113/wcrj_20201_1464

Topic: Epidemiology, Genitourinary cancer Category: Original article

Mohammadian M.

Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran Close

, Safari A.

Zabol University of Medical Sciences, Zabol, Iran Close

, Allah Bakeshei K.

Department of Social Medicine, School of Public Health, Dezful University of Medical Sciences, Dezful, Iran Close

, Allah Bakeshei F.

Student Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran Close

, Asti A.

Behbahan Faculty of Medical Sciences, Behbahan, Iran Close

, Mohammadian-Hafshejani A.

Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
amohamadii1361@gmail.com Close

, Salehiniya H.

Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran Close

, Emamiyan M.

Shoushtar Faculty of Medical Science, Shoushtar, Iran Close

, Khakpour H.

Iranshahr University of Medical Sciences, Iranshahr, Iran Close

Abstract

OBJECTIVE: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing death worldwide. The present study was conducted to investigate recent patterns of bladder cancer incidence and mortality worldwide.

PATIENTS AND METHODS: In the present study, information on the incidence and mortality of bladder cancer in different regions of the world was extracted from the International Agency for Research on Cancer (IARC) (GLOBOCAN, 2018). We provided the Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of bladder cancer per 100,000 population.

RESULTS: During 2018, 549,393 new cases of bladder cancer were diagnosed worldwide, 125,311 (22.80%) of whom were female and 424,082 (77.19%) were male. In general, the global ASIR of bladder cancer was 5.7 (2.4 in women and 9.6 in men). There were also 199,922 deaths from bladder cancer, 51,652 (25.83%) of whom were female and 148,280 (74.16%) were male. The global ASMR of bladder cancer was 1.9 (0.87 in women and 3.2 in men).

CONCLUSIONS: The highest ASIR of bladder cancer was observed in North America, in regions with too high Human Development Index (HDI) and in Europe. The highest mortality due to bladder cancer was observed in Europe, in regions with too high human development index and in EMRO.

Free PDF Download

To cite this article